Quoin Pharmaceuticals Statistics
Total Valuation
QNRX has a market cap or net worth of $2.35 million. The enterprise value is -$1.68 million.
| Market Cap | 2.35M |
| Enterprise Value | -1.68M |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, after market close.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
QNRX has 3.80 million shares outstanding. The number of shares has increased by 273.37% in one year.
| Shares Outstanding | 3.80M |
| Shares Change (YoY) | +273.37% |
| Shares Change (QoQ) | +273.37% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 6.45% |
| Float | 3.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.94 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.61, with zero debt.
| Current Ratio | 3.61 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -107.60% and return on invested capital (ROIC) is -99.30%.
| Return on Equity (ROE) | -107.60% |
| Return on Assets (ROA) | -56.00% |
| Return on Capital (ROIC) | -99.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.10M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.25% in the last 52 weeks. The beta is 2.00, so QNRX's price volatility has been higher than the market average.
| Beta (5Y) | 2.00 |
| 52-Week Price Change | -90.25% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 2.49 |
| Relative Strength Index (RSI) | 43.37 |
| Average Volume (20 Days) | 47,328 |
Short Selling Information
| Short Interest | 12,852 |
| Short Previous Month | 5,169 |
| Short % of Shares Out | 0.34% |
| Short % of Float | 0.32% |
| Short Ratio (days to cover) | 0.27 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.49M |
| Pretax Income | -2.31M |
| Net Income | -8.41M |
| EBITDA | -2.28M |
| EBIT | -2.31M |
| Earnings Per Share (EPS) | -$6.66 |
Balance Sheet
The company has $4.03 million in cash and no debt, giving a net cash position of $4.03 million or $1.06 per share.
| Cash & Cash Equivalents | 4.03M |
| Total Debt | n/a |
| Net Cash | 4.03M |
| Net Cash Per Share | $1.06 |
| Equity (Book Value) | 2.50M |
| Book Value Per Share | 0.66 |
| Working Capital | 3.03M |
Cash Flow
| Operating Cash Flow | -2.07M |
| Capital Expenditures | n/a |
| Free Cash Flow | -2.07M |
| FCF Per Share | -$0.56 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
QNRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -273.37% |
| Shareholder Yield | -273.37% |
| Earnings Yield | -357.37% |
| FCF Yield | -88.03% |
Analyst Forecast
The average price target for QNRX is $4.00, which is 545.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 545.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 18, 2023. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jul 18, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |